BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang J, Lip GYH. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes 2021;7:330-9. [PMID: 34107535 DOI: 10.1093/ehjqcco/qcab029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ferreira DA, Vida C, Mendonça É, Vieira P, Freitas S, Silva G. Effect of Protective Measures Adopted in the COVID-19 Pandemic on Hemodialysis Patients. Cureus 2023. [DOI: 10.7759/cureus.35552] [Reference Citation Analysis]
2 Kania M, Mazur K, Terlecki M, Matejko B, Hohendorff J, Chaykivska Z, Fiema M, Kopka M, Kostrzycka M, Wilk M, Klupa T, Witek P, Katra B, Klocek M, Rajzer M, Malecki MT. Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland. Int J Endocrinol 2023;2023:8700302. [PMID: 36844106 DOI: 10.1155/2023/8700302] [Reference Citation Analysis]
3 Mahabadi AA, Mincu R, Dykun I, Michel L, Küng A, Witzke O, Kill C, Buer J, Rassaf T, Totzeck M. Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 - The CoV-COR registry. Int J Cardiol Heart Vasc 2023;45:101184. [PMID: 36776683 DOI: 10.1016/j.ijcha.2023.101184] [Reference Citation Analysis]
4 Fauziyati A, Pramono BA, Widodo U. Post Covid with Pleural Effusion: A Case Report. Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021) 2023. [DOI: 10.2991/978-94-6463-048-0_5] [Reference Citation Analysis]
5 Wan KS, Sundram ER, Abdul Haddi AA, Dashuki AR, Ahad A, John R, Abdul Wahid MR, Ungku Halmie UIF, Ibrahim FE, Abdul Rahim NB. Long COVID active case detection initiative among COVID-19 patients in Port Dickson, Malaysia: a retrospective study on the positive outcomes, the proportion of patients with long COVID and its associated factors. PeerJ 2023;11:e14742. [PMID: 36915663 DOI: 10.7717/peerj.14742] [Reference Citation Analysis]
6 Szoltysek-Boldys I, Zielinska-Danch W, Loboda D, Wilczek J, Gibinski M, Paradowska-Nowakowska E, Golba KS, Sarecka-Hujar B. Photoplethysmographic Measurement of Arterial Stiffness in Polish Patients with Long-COVID-19 Syndrome-The Results of a Cross-Sectional Study. Diagnostics (Basel) 2022;12. [PMID: 36553195 DOI: 10.3390/diagnostics12123189] [Reference Citation Analysis]
7 Duddy C, Gadsby E, Hibberd V, Krska J, Wong G. Understanding what happens to attendees after an NHS Health Check: a realist review. BMJ Open 2022;12:e064237. [DOI: 10.1136/bmjopen-2022-064237] [Reference Citation Analysis]
8 Gregorczyk-maga I, Fiema M, Kania M, Kędzierska J, Jachowicz E, Romaniszyn D, Wójkowska-mach J. Cultivable oral bacteriota dysbiosis in mechanically ventilated COVID-19 patients. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1013559] [Reference Citation Analysis]
9 Onoja A, Picchiotti N, Fallerini C, Baldassarri M, Fava F, Colombo F, Chiaromonte F, Renieri A, Furini S, Raimondi F; GEN-COVID Multicenter Study. An explainable model of host genetic interactions linked to COVID-19 severity. Commun Biol 2022;5:1133. [PMID: 36289370 DOI: 10.1038/s42003-022-04073-6] [Reference Citation Analysis]
10 Reyna-Villasmil E, Caponcello MG, Maldonado N, Olivares P, Caroccia N, Bonazzetti C, Tazza B, Carrara E, Giannella M, Tacconelli E, Rodríguez-Baño J, Palacios-Baena ZR; ORCHESTRA Study. Association of Patients' Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis. Biomedicines 2022;10. [PMID: 36289699 DOI: 10.3390/biomedicines10102437] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Akkaif MA, Bitar AN, Al-kaif LAIK, Daud NAA, Sha’aban A, Noor DAM, Abd Aziz F, Cesaro A, Sk Abdul Kader MA, Abdul Wahab MJ, Khaw CS, Ibrahim B. The Management of Myocardial Injury Related to SARS-CoV-2 Pneumonia. JCDD 2022;9:307. [DOI: 10.3390/jcdd9090307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Tereshchenko LG, Bishop A, Fisher-Campbell N, Levene J, Morris CC, Patel H, Beeson E, Blank JA, Bradner JN, Coblens M, Corpron JW, Davison JM, Denny K, Earp MS, Florea S, Freeman H, Fuson O, Guillot FH, Haq KT, Kim M, Kolseth C, Krol O, Lin L, Litwin L, Malik A, Mitchell E, Mohapatra A, Mullen C, Nix CD, Oyeyemi A, Rutlen C, Tam AE, Van Buren I, Wallace J, Khan A. Risk of Cardiovascular Events After COVID-19. Am J Cardiol 2022;179:102-9. [PMID: 35843735 DOI: 10.1016/j.amjcard.2022.06.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Radandish M, Esmaeil N, Khorvash F, Andalib A. Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells, NLRP3, and Lactate Dehydrogenase in Severe/Critical COVID-19: A Prospective Longitudinal Study According to the Severe/Critical COVID-19 Definitions. Viral Immunol 2022. [PMID: 36099205 DOI: 10.1089/vim.2022.0060] [Reference Citation Analysis]
14 Sonel Tur B, Füsun Köseoğlu B, Kutay Ordu Gökkaya N, Kurtaiş Aytür Y, Özyemişci Taşkıran Ö, Demirbağ Kabayel D, Kesiktaş N, Tıkız C, Özdemir H, Alemdaroğlu E, Bilir Kaya B, Genç A, Tomruk Sütbeyaz S. COVID-19, cardiac involvement and cardiac rehabilitation: Insights from a rehabilitation perspective - State of the Art. Turk J Phys Med Rehab 2022;68:317-335. [DOI: 10.5606/tftrd.2022.11435] [Reference Citation Analysis]
15 Göbölös L, Manla Y, Rácz I, Hogan M, Remsey-semmelweis E, Atallah B, Aljabery Y, Almahmeed W, Alsindi F, Bader F, Bhatnagar G, Aleinati T, Murat Tuzcu E. Adverse Cardiac Effects of SARS-CoV-2 Infection. J Asian Pac Soc Cardiol 2022;1. [DOI: 10.15420/japsc.2022.04] [Reference Citation Analysis]
16 Canivet P, Desir C, Thys M, Henket M, Frix AN, Ernst B, Walsh S, Occhipinti M, Vos W, Maes N, Canivet JL, Louis R, Meunier P, Guiot J. The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave. Diagnostics (Basel) 2022;12. [PMID: 35885473 DOI: 10.3390/diagnostics12071567] [Reference Citation Analysis]
17 Bais B, Sozio E, De Silvestri D, Volpetti S, Zannier ME, Filì C, Bassi F, Alcaro L, Cotrufo M, Pagotto A, Giacinta A, Patruno V, Da Porto A, Sbrojavacca R, Curcio F, Tascini C, Sechi LA, Colussi G. Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis. Thromb J 2022;20:34. [PMID: 35725464 DOI: 10.1186/s12959-022-00393-z] [Reference Citation Analysis]
18 Marchioni C, Esposito G, Calci M, Bais B, Colussi G. Effect of intermediate/high versus low dose heparin on the thromboembolic and hemorrhagic risk of unvaccinated COVID-19 patients in the emergency department. BMC Emerg Med 2022;22:107. [PMID: 35698054 DOI: 10.1186/s12873-022-00668-8] [Reference Citation Analysis]
19 Mosaed R, Fasihi H, Norouzi A, Anjomanian V, Ardalan MA, Alazmani Noodeh F, Khoshdel AR. Influenza Vaccine and COVID-19 Pandemic: Could This Vaccine Help Limit the Potential Adverse Consequences of SARS-CoV-2? Iran J Pharm Res 2022;21:e127032. [PMID: 36710988 DOI: 10.5812/ijpr-127032] [Reference Citation Analysis]
20 Lambourg EJ, Gallacher PJ, Hunter RW, Siddiqui M, Miller-Hodges E, Chalmers J, Pugh D, Dhaun N, Bell S. Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study. Eur Respir J 2022:2103168. [PMID: 35551093 DOI: 10.1183/13993003.03168-2021] [Reference Citation Analysis]
21 Degarege A, Naveed Z, Kabayundo J, Brett-Major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11. [PMID: 35631084 DOI: 10.3390/pathogens11050563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tomaselli V, Ferrara P, Cantone GG, Romeo AC, Rust S, Saitta D, Caraci F, Romano C, Thangaraju M, Zuccarello P, Rose J, Ferrante M, Belsey J, Cibella F, Caci G, Ferri R, Polosa R. The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey. Intern Emerg Med 2022. [PMID: 35419722 DOI: 10.1007/s11739-022-02975-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Borlotti A, Thomaides-brears H, Georgiopoulos G, Banerjee R, Robson MD, Fusco DN, Masci P. The Additive Value of Cardiovascular Magnetic Resonance in Convalescent COVID-19 Patients. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.854750] [Reference Citation Analysis]
24 Lindgren M, Toska T, Alex C, Lundberg CE, Cronie O, Rosengren A, Adiels M, Sjöland H. BMI, sex and outcomes in hospitalised patients in western Sweden during the COVID-19 pandemic. Sci Rep 2022;12:4918. [PMID: 35318438 DOI: 10.1038/s41598-022-09027-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Triay R, Buchhanolla P, Gaudet A, Winter V, Gaudet A, Riel-romero RMS, Javalkar V, Kelley RE, Ansari J, Faraji M, Gonzalez-toledo E, Cuellar-saenz HH, Bailey S, Siddaiah H, Gavins FNE. The Spectrum of Acute Cerebrovascular Disease in Patients with COVID-19. Biomedicines 2022;10:435. [DOI: 10.3390/biomedicines10020435] [Reference Citation Analysis]
26 Tang X, Sharma A, Pasic M, Brown P, Colwill K, Gelband H, Birnboim HC, Nagelkerke N, Bogoch II, Bansal A, Newcombe L, Slater J, Rodriguez PS, Huang G, Fu SH, Meh C, Wu DC, Kaul R, Langlois MA, Morawski E, Hollander A, Eliopoulos D, Aloi B, Lam T, Abe KT, Rathod B, Fazel-Zarandi M, Wang J, Iskilova M, Pasculescu A, Caldwell L, Barrios-Rodiles M, Mohammed-Ali Z, Vas N, Santhanam DR, Cho ER, Qu K, Jha S, Jha V, Suraweera W, Malhotra V, Mastali K, Wen R, Sinha S, Reid A, Gingras AC, Chakraborty P, Slutsky AS, Jha P; Ab-C Study Investigators. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults. JAMA Netw Open 2022;5:e2146798. [PMID: 35171263 DOI: 10.1001/jamanetworkopen.2021.46798] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
27 Tereshchenko LG, Bishop A, Fisher-campbell N, Levene J, Morris CC, Patel H, Beeson E, Blank JA, Bradner JN, Coblens M, Corpron JW, Davison JM, Denny K, Earp MS, Florea S, Freeman H, Fuson O, Guillot F, Haq K, Hyde J, Khader A, Kolseth C, Kim M, Krol O, Lin L, Litwin L, Malik A, Mitchell E, Mohapatra A, Mullen C, Nix CD, Oyeyemi A, Rutlen C, Corley-stampke L, Tam A, Van Buren I, Wallace J, Khan A. Risk of Cardiovascular Events after Covid-19: a double-cohort study.. [DOI: 10.1101/2021.12.27.21268448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Monteiro S. A fresh future forged in fear and failure. Rev Port Cardiol (Engl Ed) 2021;40:929-31. [PMID: 34922699 DOI: 10.1016/j.repce.2021.11.010] [Reference Citation Analysis]
29 Jasenovec T, Radosinska D, Kollarova M, Balis P, Dayar E, Bernatova I, Zorad S, Vrbjar N, Cacanyova S, Radosinska J. Angiotensin System Modulations in Spontaneously Hypertensive Rats and Consequences on Erythrocyte Properties; Action of MLN-4760 and Zofenopril. Biomedicines 2021;9:1902. [PMID: 34944718 DOI: 10.3390/biomedicines9121902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Bengs S, Rossi A, Haberecker M, Mikail N, Meisel A, Haider A, Grämer M, Portmann A, Todorov A, Schönenberger C, Gebhard CE, Kuster GM, Regitz-Zagrosek V, Gebhard C. Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury. Sci Rep 2021;11:23993. [PMID: 34907257 DOI: 10.1038/s41598-021-03181-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Papadopoulos KI, Sutheesophon W, Manipalviratn S, Aw TC. Age and genotype dependent erythropoietin protection in COVID-19. World J Stem Cells 2021;13:1513-29. [PMID: 34786155 DOI: 10.4252/wjsc.v13.i10.1513] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
32 Rivera-Caravaca JM, Harrison SL, Buckley BJR, Fazio-Eynullayeva E, Underhill P, Marín F, Lip GYH. Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases. Cardiovasc Diabetol 2021;20:176. [PMID: 34481513 DOI: 10.1186/s12933-021-01368-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]